Nitrate esters and their use for neurological conditions
AssigneeQueen's University at Kingston
InventorsGregory R. J. Thatcher, Brian M. Bennett, James N. Reynolds, Roland J. Boegman, Khem Jhamandas
Life of this patent
Estimating the term…
Abstract
Aliphatic nitrate esters having a sulfur or phosphorus atom .beta. or .gamma. to a nitrate group and their congeners having efficacy as neuroprotective agents are described. Preferred nitrate esters may be synthesized by nitration of a 3-bromo-1,2-propanediol, and subsequent reaction to yield the desired mono-, di- or tetra-nitrate ester.
Claims21
An aliphatic nitrate ester or salt thereof, containing at least one nitrate group, in which a S or P atom is situated .beta. or .gamma. to a nitrate group, or their congener, having a general formula:
- ##STR6## where X is CN, NHOH, N.sub.2 H.sub.3, N.sub.2 H.sub.2 R.sub.13, N.sub.2 HR.sub.13 R.sub.14, N.sub.3, SCN, SCN.sub.2 H.sub.2 (R.sub.5).sub.2, SCN.sub.2 H.sub.3 (R.sub.5), SC(O)N(R.sub.5).sub.2, SC(O)NHR.sub.5, CO.sub.2 M, CO.sub.2 H, CO.sub.2 R.sub.11, C(O), C(O)R.sub.12, C(O)(OR.sub.13), PO.sub.2 M, P(O)(OR.sub.14), P(O)(R.sub.13), SO, SO.sub.2, C(O)(SR.sub.13), or SSR.sub.4 ;
- Y is SCN, SCN.sub.2 H.sub.2 (R.sub.5).sub.2, SC(O)NHR.sub.5, SC(O)N(R.sub.5).sub.2, SR.sub.4, SR.sub.10, SSR.sub.10, SO.sub.2 M, SO.sub.3 M, PO.sub.3 HM, PO.sub.3 M.sub.2, P(O)(OR.sub.5)(OR.sub.6), or P(O)(OR.sub.6)(OM), CN, N.sub.3, N.sub.2 H.sub.2 R.sub.13, N.sub.2 HR.sub.13 R.sub.14, CO.sub.2 M, CO.sub.2 H, CO.sub.2 R.sub.11, C(O)R.sub.12, C(O)(SR.sub.13), or does not exist;
- R.sub.5, R.sub.6, R.sub.8, R.sub.9, R.sub.10, R.sub.12, R.sub.13, R.sub.14, R.sub.15, R.sub.16, are the same or different alkyls containing 1-12 carbon atoms which may contain 1-4 ONO.sub.2 substituents or C.sub.1 or C.sub.2 connections to R.sub.1 -R.sub.3 in cyclic derivatives;
- R.sub.7, R.sub.11, are C.sub.1 -C.sub.8 alkyl or acyl;
- R.sub.2 and R.sub.4 are the same or different and selected from H, ONO.sub.2, C.sub.1 -C.sub.4 alkyl optionally bearing 1-3 nitrate groups, and acyl groups (--C(O)R.sub.10);
- R.sub.1 and R.sub.3 are the same or different and selected from H, C.sub.1 -C.sub.4 alkyl and chains, which may include one O, linking R.sub.1 and R.sub.3 to form pentosyl, hexosyl, cyclopentyl or cycohexyl rings, which rings optionally bear hydroxyl substituents;
- and
- M is H, Na.sup.+, K.sup.+, NH.sub.4.sup.+ or N.sup.+ H.sub.n R.sub.11(4-n) where n is 0-3;
- and with the proviso that, when R.sub.5 is an alkyl group, and R.sub.1 R.sub.2 and R.sub.4 are H, R.sub.3 is not H or methyl.
An aliphatic nitrate ester having a formula selected from the group consisting of:
- ##STR7##
A pharmaceutical composition comprising an effective amount of an aliphatic nitrate ester or a pharmaceutically acceptable salt thereof, having the formula:
- ##STR8## where X is CN, NHOH, N.sub.2 H.sub.3, N.sub.2 H.sub.2 R.sub.13, N.sub.2 HR.sub.13 R.sub.14, N.sub.3, SCN, SCN.sub.2 H.sub.2 (R.sub.5).sub.2, SCN.sub.2 H.sub.3 (R.sub.5), SC(O)N(R.sub.5).sub.2, SC(O)NHR.sub.5, CO.sub.2 M, CO.sub.2 H, CO.sub.2 R.sub.11, C(O), C(O)R.sub.12, C(O)(OR.sub.13), PO.sub.2 M, P(O)(OR.sub.14), P(O)(R.sub.13), SO, SO.sub.2, C(O)(SR.sub.13), or SSR.sub.4 ;
- Y is SCN, SCN.sub.2 H.sub.2 (R.sub.5).sub.2, SC(O)NHR.sub.5, SC(O)N(R.sub.5).sub.2, SR.sub.4, SR.sub.10, SSR.sub.10, SO.sub.2 M, SO.sub.3 M, PO.sub.3 HM, PO.sub.3 M.sub.2, P(O)(OR.sub.5)(OR.sub.6), or P(O)(OR.sub.6)(OM), CN, N.sub.3, N.sub.2 H.sub.2 R.sub.13, N.sub.2 HR.sub.13 R.sub.14, CO.sub.2 M, CO.sub.2 H, CO.sub.2 R.sub.11, C(O)R.sub.12, C(O)(SR.sub.13), or does not exist;
- R.sub.5, R.sub.6, R.sub.8, R.sub.9, R.sub.10,R.sub.12, R.sub.13, R.sub.14, R.sub.15, R.sub.16, are the same or different alkyls containing 1-12 carbon atoms which may contain 1-4 ONO.sub.2 substituents or C.sub.1 or C.sub.2 connections to R.sub.1 -R.sub.3, in cyclic derivatives;
- R.sub.7, R.sub.11 are C.sub.1 -C.sub.8, alkyl or acyl,
- R.sub.2 and R.sub.4 are the same or different and selected from H, ONO.sub.2, C.sub.1 -C.sub.4 alkyl optionally bearing 1-3 nitrate groups, and acyl groups (--C(O)R.sub.10);
- R.sub.1 and R.sub.3 are the same or different and selected from H, C.sub.1 -C.sub.4 alkyl and chains, which may include one O, linking R.sub.1 and R.sub.3 to form pentosyl, hexosyl, cyclopentyl or cycohexyl rings, which rings optionally bear hydroxyl substituents;
- and
- M is H, Na.sup.+, K.sup.+, NH.sub.4.sup.+ or N.sup.+ H.sub.n R.sub.11(4-n) where n is 0-3;
- and with the proviso that, when R.sub.6 is an alkyl group, and R, R.sub.2 and R.sub.4 are H, R.sub.3 is not H or methyl;
- in admixture with a pharmaceutically acceptable carrier therefor.
A pharmaceutical composition comprising a nitrate ester having a formula selected from the group consisting of:
- ##STR9##
An aliphatic nitrate ester or salt thereof, containing at least one nitrate group, in which a S or P atom is situated .beta. or .gamma. to a nitrate group, or their congener, having a general formula:
- ##STR10## where X is CH.sub.2, O, NH, S or NCH.sub.3 ;
- Y is SCN, SCN.sub.2 H.sub.2 (R.sub.5).sub.2, SC(O)NHR.sub.5, SC(O)N(R.sub.5).sub.2, CN, N.sub.3, N.sub.2 H.sub.2 R.sub.13, N.sub.2 HR.sub.13 R.sub.14, CO.sub.2 M, CO.sub.2 H, CO.sub.2 R.sub.11, C(O)R.sub.12, C(O)(SR.sub.13);
- R.sub.5, R.sub.6, R.sub.8, R.sub.9, R.sub.10, R.sub.12, R.sub.13, R.sub.14, R.sub.15, R.sub.16, are the same or different alkyls containing 1-12 carbon atoms which may contain 1-4 ONO.sub.2 substituents or C.sub.1 or C.sub.2 connections to R.sub.1 -R.sub.3 in cyclic derivatives;
- R.sub.7, R.sub.11 are C.sub.1 -C.sub.8, alkyl or acyl;
- R.sub.2 and R.sub.4 are the same or different and selected from H, ONO.sub.2, C.sub.1 -C.sub.4 alkyl optionally bearing 1-3 nitrate groups, and acyl groups (--C(O)R.sub.10);
- R.sub.1 and R.sub.3 are the same or different and selected from H, C.sub.1 -C.sub.4 alkyl and chains, which may include one O, linking R.sub.1 and R.sub.3 to form pentosyl, hexosyl, cyclopentyl or cycohexyl rings, which rings optionally bear hydroxyl substituents;
- and
- M is H, Na.sup.+, K.sup.+, NH.sub.4.sup.+ or N.sup.+ H.sub.n R.sub.11(4-n) where n is 0-3;
- and with the proviso that, when X is O, Y is not C(O)R.sub.l2,
- and with the proviso that, when R.sub.5 is an alkyl group, and R, R.sub.2 and R.sub.4 are H, R.sub.3 is not H or methyl.
An aliphatic nitrate ester or salt thereof, containing at least one nitrate group, in which a S or P atom is situated .beta. or .gamma. to a nitrate group, or their congener, having a general formula:
- ##STR11## where X is SCN, CH.sub.2, SCN.sub.2 H.sub.3 (R.sub.5), C(O), C(O)R.sub.12, C(O)(OR.sub.13), C(O)(SR.sub.13), or NCH.sub.3 ;
- Y is SCN, SCN.sub.2 H.sub.2 (R.sub.5).sub.2, CO.sub.2 R.sub.11, C(O)R.sub.12, C(O)(SR.sub.13), or does not exist;
- R.sub.5, R.sub.6, R.sub.8, R.sub.9, R.sub.10, R.sub.12, R.sub.13, R.sub.14,R.sub.15, R.sub.16, are the same or different alkyls containing 1-12 carbon atoms which may contain 1-4 ONO.sub.2 substituents or C.sub.1 or C.sub.2 connections to R.sub.1 -R.sub.3 in cyclic derivatives;
- R.sub.7, R.sub.11 are C.sub.1 -C.sub.8, alkyl or acyl;
- R.sub.2 and R.sub.4 are the same or different and selected from H, ONO.sub.2, C.sub.1 -C.sub.4 alkyl optionally bearing 1-3 nitrate groups, and acyl groups (--C(O)R.sub.10);
- R.sub.1 and R.sub.3 are the same or different and selected from H, C.sub.1 -C.sub.4 alkyl and chains, which may include one O, linking R.sub.1 and R.sub.3 to form pentosyl, hexosyl, cyclopentyl or cycohexyl rings, which rings optionally bear hydroxyl substituents;
- and
- M is H, Na.sup.+, K.sup.+, NH.sub.4.sup.+ or N.sup.+ H.sub.n R.sub.11(4-n) where n is 0-3;
- and with the proviso that, when R.sub.6 is an alkyl group, and R.sub.1 R.sub.2 and R.sub.4 are H, R.sub.3 is not H or methyl.
A method for making a nitrate ester having a formula selected from the group consisting of:
- ##STR12## comprising;
- nitrating a corresponding substituted alcohol with a nitrating reagent, selected from a mixture of nitric acid and sulfuric acid in a mixture of water and an organic solvent, a nitrate salt and sulfuric acid in a mixture of water and an organic solvent, and nitronium tetrafluoroborate, and recovering therefrom the selected nitrate ester.
A method for making a nitrate ester having a formula selected from the group consisting of:
- ##STR13## comprising, nitrating a corresponding halo-alkanol with a mixture of nitric acid and sulfuric acid in methylene dichloride and recovering therefrom a halo-alkyl nitrate;
- and reacting said halo-alkyl nitrate with Na.sub.2 S.sub.2 O.sub.3 so as to produce the selected Bunte salt (2) or (8).
A method for making a nitrate ester having a formula selected from the group consisting of:
- ##STR15## comprising:
- nitrating bis-(2, 3-dihydroxy propyl) disulfide in a mixture of aqueous nitric acid and sulfuric acid in methylene dichloride, and separating the desired product therefrom chromatographically.
A method for making a nitrate ester having a formula:
- ##STR16## comprising:
- sllylating 3-bromopropane-1, 2-diol, treating said silyl ester with triethyl phosphite to produce a phosphonate, and nitrating said phosphonate to produce said nitrate ester.
A method for making a nitrate ester having a formula:
- ##STR17## comprising:
- reacting triethyl phosphite with 1-bromo-2,3-epoxypropane to produce 1-phosphono-2,3-epoxypropane, and nitrating said 1-phosphono-2,3-epoxypropane to produce said nitrate ester.
A method for making a nitrate ester having a formula:
- ##STR18## comprising:
- reacting a thioacetate salt with 2-bromoethyl nitrate to produce said nitrate monoester.
A method for making a nitrate ester having a formula:
- ##STR19## comprising:
- reacting a thiocyanate salt with 3-bromo-1, 2-propane dinitrate to produce said nitrate ester.
A method for making a nitrate ester having a formula:
- ##STR20## comprising:
- reacting a cyanide salt with 3-bromo-1, 2-propane dinitrate to produce said nitrate ester.
Dependencies are inferred from the claim text.